ZW17385A1 - Tricyclic pyridine derivatives - Google Patents

Tricyclic pyridine derivatives

Info

Publication number
ZW17385A1
ZW17385A1 ZW173/85A ZW17385A ZW17385A1 ZW 17385 A1 ZW17385 A1 ZW 17385A1 ZW 173/85 A ZW173/85 A ZW 173/85A ZW 17385 A ZW17385 A ZW 17385A ZW 17385 A1 ZW17385 A1 ZW 17385A1
Authority
ZW
Zimbabwe
Prior art keywords
pyridine derivatives
tricyclic pyridine
tricyclic
derivatives
pyridine
Prior art date
Application number
ZW173/85A
Other languages
English (en)
Inventor
Fischer Ulf
Schneider Fernand
Widmer Ulrich
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZW17385A1 publication Critical patent/ZW17385A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C07D455/06—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZW173/85A 1984-11-06 1985-10-02 Tricyclic pyridine derivatives ZW17385A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH530484 1984-11-06
CH383685 1985-09-05

Publications (1)

Publication Number Publication Date
ZW17385A1 true ZW17385A1 (en) 1986-02-19

Family

ID=25693960

Family Applications (1)

Application Number Title Priority Date Filing Date
ZW173/85A ZW17385A1 (en) 1984-11-06 1985-10-02 Tricyclic pyridine derivatives

Country Status (23)

Country Link
US (2) US4735940A (fr)
EP (2) EP0183994B1 (fr)
JP (1) JPH0692405B2 (fr)
CN (1) CN1016871B (fr)
AR (1) AR242579A1 (fr)
AT (1) ATE51232T1 (fr)
AU (1) AU584132B2 (fr)
CA (1) CA1277659C (fr)
DE (2) DE3576691D1 (fr)
DK (1) DK507685A (fr)
DO (1) DOP1985004378A (fr)
ES (8) ES8705436A1 (fr)
FI (1) FI89049C (fr)
GB (1) GB2169288B (fr)
HU (1) HU205353B (fr)
IE (1) IE58850B1 (fr)
IL (1) IL76894A (fr)
IS (1) IS1469B6 (fr)
MC (1) MC1707A1 (fr)
MY (1) MY103172A (fr)
NO (1) NO171914C (fr)
PT (1) PT81431B (fr)
ZW (1) ZW17385A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889848A (en) * 1984-11-06 1989-12-26 Hoffmann-La Roche Inc. Tricyclic pyridine derivatives
NO162285C (no) * 1984-11-23 1989-12-06 Fujisawa Pharmaceutical Co Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolizinon-derivater.
CA1317945C (fr) * 1985-12-13 1993-05-18 Ulf Fischer Derives de pyridazopyridone tricyclique
EP0294599A3 (fr) * 1987-06-12 1990-05-09 F. Hoffmann-La Roche Ag Dérivés tricycliques de la pyridone
ATE145208T1 (de) * 1990-07-06 1996-11-15 Yoshitomi Pharmaceutical Kondensierte thiophenverbindungen und deren verwendung
CA2058640A1 (fr) * 1991-01-25 1992-07-26 Richard R. Scherschlicht Derive tricyclique de pyridone
US5532240A (en) * 1991-12-26 1996-07-02 Yoshitomi Pharmaceutical Industries, Ltd. Condensed thiophene compound and pharmaceutical use thereof
FR2689129B1 (fr) * 1992-03-27 1995-05-12 Atochem Elf Sa Nouveaux dérivés de l'acide 3-mercapto-2-thénoique et leurs procédés de préparation.
EP0650966A1 (fr) * 1993-10-28 1995-05-03 F. Hoffmann-La Roche Ag Procédé pour la préparation d'un dérivé de benzo(a)quinolizinone
US5869500A (en) * 1996-12-13 1999-02-09 Hoffmann-La Roche Inc. Pyridone compounds useful in treating Alzheimer's disease
GB9708945D0 (en) * 1997-05-01 1997-06-25 Merck Sharp & Dohme Therapeutic agents
GB0119828D0 (en) * 2001-08-14 2001-10-10 Merck Sharp & Dohme Therapeutic agents
GB0119803D0 (en) * 2001-08-14 2001-10-10 Merck Sharp & Dohme Therapeutic agents
ATE533782T1 (de) 2006-01-13 2011-12-15 Univ Pennsylvania Impfstoffe und immuntherapeutika mit codon- optimiertem il-15 und verwendungsverfahren dafür
AU2014306271A1 (en) 2013-08-08 2016-03-24 The Scripps Research Institute A method for the site-specific enzymatic labelling of nucleic acids in vitro by incorporation of unnatural nucleotides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC1289A1 (fr) * 1978-10-13 1980-07-22 Hoffmann La Roche Phenyl quinolizidines
EP0067565A1 (fr) * 1981-06-16 1982-12-22 Beecham Group Plc Benzamides bicycliques, leur procédé de préparation et leur application
GB8408292D0 (en) * 1984-03-30 1984-05-10 Fujisawa Pharmaceutical Co Quinolizinone compound
GB8420602D0 (en) * 1984-08-14 1984-09-19 Wyeth John & Brother Ltd Thienoquinolizines
NO162285C (no) * 1984-11-23 1989-12-06 Fujisawa Pharmaceutical Co Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolizinon-derivater.
GB8509435D0 (en) * 1985-04-12 1985-05-15 Beecham Group Plc Intermediates & process
AU582663B2 (en) * 1985-08-10 1989-04-06 John Wyeth & Brother Limited Sulphonamides
US4686226A (en) * 1985-09-03 1987-08-11 Merck & Co., Inc. Substituted benzo[b]furo- and benzo[b]thieno quinolizines

Also Published As

Publication number Publication date
IE58850B1 (en) 1993-11-17
ES8800936A1 (es) 1987-12-01
ES554427A0 (es) 1987-12-01
DE3576691D1 (de) 1990-04-26
HUT38638A (en) 1986-06-30
AU584132B2 (en) 1989-05-18
EP0318682B1 (fr) 1993-03-31
NO854404L (no) 1986-05-07
JPH0692405B2 (ja) 1994-11-16
ES8800939A1 (es) 1987-12-01
ES554430A0 (es) 1987-12-01
IL76894A (en) 1989-06-30
ES8705436A1 (es) 1987-05-01
DK507685A (da) 1986-05-07
DOP1985004378A (es) 1991-04-05
ES554432A0 (es) 1987-12-01
FI89049B (fi) 1993-04-30
JPS61115082A (ja) 1986-06-02
NO171914C (no) 1993-05-19
AU4924185A (en) 1986-05-15
CA1277659C (fr) 1990-12-11
PT81431B (pt) 1988-03-03
PT81431A (en) 1985-12-01
ES554429A0 (es) 1987-12-01
ES554431A0 (es) 1987-12-01
GB2169288A (en) 1986-07-09
AR242579A1 (es) 1993-04-30
US5036066A (en) 1991-07-30
ATE51232T1 (de) 1990-04-15
DE3587235D1 (en) 1993-05-06
ES8800933A1 (es) 1987-12-01
FI89049C (fi) 1993-08-10
EP0183994A1 (fr) 1986-06-11
ES8800937A1 (es) 1987-12-01
ES8800934A1 (es) 1987-12-01
CN1016871B (zh) 1992-06-03
GB8527196D0 (en) 1985-12-11
IL76894A0 (en) 1986-02-28
FI854211A0 (fi) 1985-10-28
IE852751L (en) 1986-05-06
ES548532A0 (es) 1987-05-01
NO171914B (no) 1993-02-08
GB2169288B (en) 1989-06-01
IS3054A7 (is) 1986-05-07
ES8800932A1 (es) 1987-12-01
IS1469B6 (is) 1991-09-24
EP0183994B1 (fr) 1990-03-21
DK507685D0 (da) 1985-11-04
EP0318682A2 (fr) 1989-06-07
MC1707A1 (fr) 1986-09-22
HU205353B (en) 1992-04-28
MY103172A (en) 1993-05-29
ES8800935A1 (es) 1987-12-01
US4735940A (en) 1988-04-05
CN85108120A (zh) 1986-11-05
ES554426A0 (es) 1987-12-01
EP0318682A3 (en) 1989-08-16
ES554428A0 (es) 1987-12-01

Similar Documents

Publication Publication Date Title
EP0195413A3 (en) Substituted pyridine derivatives
EP0194153A3 (en) Pyridine derivatives
GB2173788B (en) Pyridine derivatives
AU584132B2 (en) Tricyclic pyridine derivatives
GB8514278D0 (en) Pyridine derivatives
GB8616238D0 (en) Pyridine derivatives
GB8509276D0 (en) Pyridine derivatives
AR242212A1 (es) Un proceso para la preparacion de nuevos derivados de 1,3-dihidro-6-¡1- ciano-1-isopropil-n-fenetil-n-metil-omega-aminoalquil-7-hidro xi-furo-(3,4c)-piridina
GB8426738D0 (en) Pyridine derivatives
GB8422461D0 (en) Pyridine derivatives
GB8503426D0 (en) Pyridine derivatives
ZA855829B (en) Tricyclic quinoline derivatives
GB8520007D0 (en) Pyridine derivatives
GB8507008D0 (en) Pyridine derivatives
GB8521304D0 (en) Pyridine derivatives
GB8520169D0 (en) Pyridine derivatives
GB2200117B (en) Tricyclic pyridine derivatives
GB2162180B (en) Pyridone derivatives
GB2167064B (en) Pyridine derivatives
ZA858351B (en) Tricyclic pyridine derivatives
IL88046A0 (en) Tricyclic pyridine derivatives
GB8413690D0 (en) Pyridine derivatives
GB8413688D0 (en) Pyridine derivatives
GB8413499D0 (en) Pyridine derivatives
GB8405999D0 (en) Pyridine derivatives